Micheau · Cell 2003 · in vitro molecular biology mechanistic study · n=?

Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.

Cited 2711 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

In vitro mechanistic research (CEBM Level 5).

PubMed 12887920 · doi:10.1016/s0092-8674(03)00521-x · record verified 2026-08-29

What was done

Investigated the molecular mechanism governing the cell death versus survival decision downstream of TNF-receptor I (TNFR1) by characterizing the formation and composition of sequential receptor-associated protein complexes.

What was found

TNFR1 signaling was shown to occur through two sequential complexes. Complex I forms at the plasma membrane (containing TNFR1, TRADD, RIP1, and TRAF2) and rapidly activates NF-kappa B. TRADD and RIP1 subsequently associate with FADD and caspase-8 to form complex II in the cytoplasm. Successful NF-kappa B activation by complex I leads to incorporation of the caspase-8 inhibitor FLIP(L) into complex II to promote survival; failure to activate NF-kappa B allows complex II to trigger apoptosis. No numerical values or statistics were reported in the abstract.

Why it matters

This study defines the classic two-complex checkpoint model of TNFR1 signal transduction, explaining how cells temporally arbitrate between pro-survival NF-kappa B signaling and apoptotic cell death.

Limits

The abstract describes qualitative molecular pathways without quantitative metrics, effect sizes, or variance. Cell lines, experimental sample sizes, and in vivo applicability are not specified in the abstract.

Cited by